UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050734
Receipt number R000057808
Scientific Title Do Personal Health Records Promote Malaria Prevention? An Experimental Investigation in Kenya
Date of disclosure of the study information 2024/04/01
Last modified on 2024/01/06 16:46:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Do Personal Health Records Promote Malaria Prevention? An Experimental Investigation in Kenya

Acronym

PHRMalExpKny

Scientific Title

Do Personal Health Records Promote Malaria Prevention? An Experimental Investigation in Kenya

Scientific Title:Acronym

PHRMalExpKny

Region

Africa


Condition

Condition

Malaria

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the impact of personal health records on subjective immunity, preventive behaviours, and test positivity of malaria in Homa Bay, Kenya

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

(1) PCR malaria positivity; (2) RDT malaria positivity;

Key secondary outcomes

(1) subjective immunity against malaria; (2) preventive behaviours of malaria;


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Intervention: own malaria RDT results are summarised and reminded to randomly selected individuals.

Interventions/Control_2

Control: no additional information is provided.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Everyone included in the cohort survey study that recruits participants according to the following inclusion criteria: (1) being between 5 and 65 years old; (2) having no plans to leave the study area; (3)having no plans to live outside the study area for an extended period (longer than one month) over the entire duration of the study (i.e., 18-months) and (4) providing informed consent.

Key exclusion criteria

This study has no exclusion criteria other than the cohort survey study that has the following: (1) showing signs of severe illnesses; (2) having a known chronic condition or immunodeficiency, including HIV infection; (3) being pregnant at the time of enrolment; (4) planning to leave the study area; or (4) failing to provide informed consent.

Target sample size

325


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Kaneko

Organization

Osaka Metropolitan University

Division name

Graduate School of Medicine

Zip code

545-8585

Address

1-4-3 Asahi-machi, Abeno-Ku, Osaka, Japan

TEL

666453761

Email

akirakaneko555@gmail.com


Public contact

Name of contact person

1st name Masaru
Middle name
Last name Nagashima

Organization

Waseda University

Division name

Waseda Institute for Advanced Study

Zip code

169-0051

Address

Rm 415-1, 1-21-1 Nishiwaseda, Shinjuku, Tokyo

TEL

352862120

Homepage URL


Email

mnagashima@aoni.waseda.jp


Sponsor or person

Institute

Osaka Metropolitan University

Institute

Department

Personal name



Funding Source

Organization

Hitachi Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Mount Kenya University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan External Trade Organization Institute of Developing Economies

Address

3-2-2 Wakaba, Mihamaku, Chiba City, Chiba 261-8545

Tel

432999526

Email

kenki@ide.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 03 Month 14 Day

Date of IRB

2023 Year 03 Month 22 Day

Anticipated trial start date

2023 Year 04 Month 24 Day

Last follow-up date

2023 Year 11 Month 19 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 31 Day

Last modified on

2024 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057808


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name